Literature DB >> 6571912

Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease.

H Olsson, M Landin-Olsson, B Gullberg.   

Abstract

The length of the menstrual cycle was compared in women with breast cancer, women with benign breast disease, and controls. Older women in general tended to report shorter menstrual cycles (P less than 0.05). After correction for the age difference, breast cancer patients still reported a shorter average menstrual cycle length than benign breast disease patients and controls (P less than 0.006). Very short cycles (less than or equal to 21 days) were present in 20% of the breast cancer patients compared to 8% of the patients with benign breast disease and 4% of the controls (P less than 0.0001). Long cycles (less than or equal to 30 days) were not a feature of breast cancer patients (2%), whereas 20% of the patients with benign breast disease and 20% of the controls reported such long cycles (P less than 0.0001). Irregular menstrual cycles were more common in benign breast disease patients (20%) than in cancer patients (10%) and controls (8%) (P less than 0.001).

Entities:  

Mesh:

Year:  1983        PMID: 6571912

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies.

Authors:  L Bernstein; J M Yuan; R K Ross; M C Pike; R Hanisch; R Lobo; F Stanczyk; Y T Gao; B E Henderson
Journal:  Cancer Causes Control       Date:  1990-07       Impact factor: 2.506

Review 2.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Lifetime menstrual activity--indicator of breast cancer risk.

Authors:  M Rautalahti; D Albanes; J Virtamo; J Palmgren; J Haukka; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

4.  Risk factors for histologically confirmed benign breast tumors.

Authors:  M Rautalahti; D Albanes; J Haukka; J Virtamo
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

Review 5.  Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Authors:  Leena Hilakivi-Clarke; Sonia de Assis; Anni Warri
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-08       Impact factor: 2.673

Review 6.  Phytoestrogens and reproductive biology.

Authors:  Teruhiko Tamaya
Journal:  Reprod Med Biol       Date:  2005-11-02

7.  Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project.

Authors:  I den Tonkelaar; F de Waard
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Menstrual and reproductive factors and risk of breast cancer in Asian-Americans.

Authors:  A H Wu; R G Ziegler; M C Pike; A M Nomura; D W West; L N Kolonel; P L Horn-Ross; J F Rosenthal; R N Hoover
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

9.  The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention.

Authors:  L Bernstein; R K Ross; R A Lobo; R Hanisch; M D Krailo; B E Henderson
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

10.  Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.

Authors:  Annelie Johansson; Athanasia E Christakou; Adina Iftimi; Mikael Eriksson; Jose Tapia; Lambert Skoog; Christopher C Benz; Kenny A Rodriguez-Wallberg; Per Hall; Kamila Czene; Linda S Lindström
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.